GRI Bio adjourns 2024 annual meeting to Sept 6 to solicit more proxies for outstanding proposals

GRI Bio, Inc.

Only 34.58% of shares present (256,566 of 741,914); quorum was barely met at one-third threshold.
Adjournment proposal passed with 157,455 for, 99,095 against, 16 abstain; no broker non-votes.
Meeting adjourned to September 6, 2024 at 11 a.m. ET; voting on other agenda items postponed.
Company plans to solicit additional proxies to adopt remaining proposals from the proxy statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.